Reuters logo
BRIEF-GL Pharm Tech gets exclusive right to provide GLG3PO stomatitis medicine
January 5, 2017 / 6:48 AM / 10 months ago

BRIEF-GL Pharm Tech gets exclusive right to provide GLG3PO stomatitis medicine

Jan 5 (Reuters) - GL Pharm Tech Corp :

* Says it signed contract with DKSH Korea to get exclusive right to provide GLG3PO(stomatitis medicine)

* Says the revenue of the company for FY 2017 is expected to be 556 million won

Source text in Korean: goo.gl/qJ0QoN

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below